These results provide strong evidence to support the hypothesis that RhoB is a tumor suppressor in ccRCC, and miR-19a and miR-19b may act as oncomirs and down-regulate RhoB expression in ccRCC through a post-transcriptional mechanism. The gene discussed is RHOB; the disease is nonpapillary renal cell carcinoma.